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Summary Mice were immunized with cultured cells derived from transitional cell carcinoma of the human
urinary bladder (TCC). Spleen cells were fused with mouse myeloma cell line Sp2/0-Agl4 and the hybridomas
obtained screened for antibody production against a panel of human cells. Two hybridomas were selected for
further studies. The antibodies from one of these hybridomas (P7A5-4) could clearly discriminate between
malignant and normal cells from the bladder, both when tested with cultured cells and fresh tissue. The P7A5-
4 antibodies, however, also reacted with some non-TCC cultured carcinoma and melanoma cells but to a
lesser extent. This difference in reactivity was even more pronounced in the fresh tumours tested, thus
indicating a quantitative difference in antigen expression between TCC and other cells. From extracts of TCC
cells, P7A5-4 bound three polypeptides of mol. wts 92Kd (ConA+), 23 and 17Kd (ConA-). The antibody
derived from hybridoma SK4H-12 bound a ConA reactive glycopeptide of 1OOKdmol.wt, the expression of
which was almost entirely restricted to urothelial cell lines and tissue of TCC origin, as shown by
immunocytochemical studies. The finding in this study of new antigens associated with urinary bladder
carcinoma, extend the results obtained previously in our laboratory (Koho et al., 1984; Paulie et al., 1984)
and further delineate the heterogeneity of tumour-associated antigens in this human tumour system.
The search for antigens associated with human
tumours (TAA) continues to be a field attracting
much interest. Although it is becoming increasingly
clear that TAAs are rarely, if ever, completely
tumour restricted, quantitative differences in
antigen expression between malignant and normal
cells have often proved to be sufficient to make
them valuable in the diagnosis and therapy of some
tumours (Deland & Goldenberg, 1983; Mach et al.,
1983; Larson et al., 1983; Sears et al., 1984). In
addition, information regarding the function of
these molecules may be important for the
understanding of their possible role in oncogenesis.
Recent reports on different tumour antigens
associated with urinary bladder cancer (Fradet et
al., 1984; Mazuko et al., 1984; Koho et al., 1984;
Messing et al., 1984; Grossman, 1983) suggest the
existence of a complex group of TAAs similar to
what has been found for melanomas (for review see
Hellstr6m et al., 1985). In this study we describe
the production and specificity patterns of two new
monoclonal antibodies extending our earlier
analysis of the heterogeneity of TAAs in human
bladder carcinoma. The monoclonal antibodies
tested were secreted by hybridomas obtained from
Balb/c mice immunized with cells from 2 different
TCC cell lines (TCCSuP and SD). By means of a
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cell-ELISA, indirect immunofluorescence (IFL) and
immunoperoxidase staining, the specificities of these
antibodies were investigated against a panel of cells
as well as tissue of normal or tumour origin. The
antigens recognized by the antibodies were defined
by immunoprecipitation followed by SDS-PAGE
and autoradiography.
Materials and methods
Cell lines and tissues
The target cells used in the cell-ELISA and IFL are
given in Table I. The culturing conditions and other
data for these cells have been given elsewhere
(Koho et al., 1984).
Surgical specimens were collected immediately
after surgery, snap frozen in liquid nitrogen and
stored at -70°C until sectioned.
Immunization andproduction ofhybridomas
Two Balb/c mice were immunized as follows: one
was injected twice i.p. with 107 TCCSuP cells in
PBS (pH7.2), the second was injected once i.p. with
2.5 x 106 SD cells in PBS. Both were boostered with
18 x 106 cells 10 weeks later. For fusion and
production of hybridomas, the methodology
described by Fazekas de St Groth & Scheidegger
(1980) was applied. Spleen cells from immune mice
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were taken 4 days after the last injection and fused
with myeloma cells (Sp 2/0) at a ratio of 1:1 using
50% polyethylene glycol (Merck, West Germany,
mol. w. 4000) in saline as fusing agent. After fusion
the cells were suspended in HAT-medium at a
concentration of1.5-2 x I05 ml- anddistributedinto
microtiter plates (No. 76-033-05, Flow Laboratories
Ltd., Irvine, Scotland) in 0.2ml/well containing
0.5-104 syngeneic mouse macrophages. Growing
hybridomas were seen 6-10 days after fusion.
Supernatants from growing colonies were tested for
specific antibody production, and cell populations
of interest were expanded by subculturing first in
2ml wells (No. 2534, Flow Laboratories) and then
in cell culture flasks (Nunc, Roskilde, Denmark) for
freezing, cloning and antibody analysis. Cloning
was carried out by limiting dilution using one
cell/well in microtiter plates containing normal
syngeneic peritoneal macrophages as feeder cells (5-
10 x 103/well). Only cells from wells with one
growing colony, as checked by microscopy, were
selected for further use.
Enzyme linked immunosorbent assay (ELISA)
This assay was a modification of the method
originally reported by Engvall & Perlmann (1971)
and described in detail by Koho et al. (1984). In a
few cases in which conjugates based on alkaline
phosphatase (ALP) could not be used because of
endogeneous ALP activity of the target cells, horse-
radish peroxidase linked sheep F(ab') anti-mouse
immunoglobulin (Amersham, Bucks., UK) was used
as conjugate in the ELISA assay. In these cases, the
reactions were revealed by addition of 100M1 of
2,2'-azino-di-3-ethylbenzthiazoline sulfonate.
Indirect immunofluorescence and immunoperoxidase
assays
The binding specificities of the antibodies were
determined against cultured cells, adhered to
multitest slides, by IFL as described elsewhere
(Koho et al., 1984). The specificity of antibodies
was also analysed by IFL and immunoperoxidase
(Nakane & Pearce, 1966) on frozen sections of
human tumours and normal tissue. Six to 8 um
thick cryostat sections were fixed for 5min with 1%
formaldehyde in PBS, washed extensively in buffer
with 1% bovine serum albumin and incubated with
10 times diluted hybridoma supernatant for 30min.
For IFL, the slides were washed and incubated for
an additional 30min with rabbit F(ab')2 anti-mouse
immunoglobulin (Ig) conjugated to fluorescein
isothiocyanate (Clark & Shepard, 1963), washed
again and mounted in 50% glycerol in PBS prior to
examination. For immunoperoxidase staining, the
slides were incubated with sheep F(ab')2 anti-mouse
Ig coupled to horseradish peroxidase (Amersham)
for 30min and washed. The peroxidase reaction
was initiated by addition of 0.06% diamino-
benzidine (Sigma Chemical Co., St Louis, Mo,
USA) and 0.01% H202 in PBS and continued for
5-7min after which the slides were washed and
mounted as above.
Parallel sections from all tissues were also stained
with hematoxylin and examined for morphological
details.
Determination ofthe immunoglobulin subclass of
hybridoma antibodies
Supernatants from growing hybridomas (10p1) were
allowed to diffuse in 1% agarose gel against the
same amount of class or subclass specific rabbit
anti-mouse immunoglobulin antibodies (Bionetics,
Kensington, Md, USA). The gels were incubated
for 48h in a humid chamber and stained with
Coomassie brilliant blue R (Sigma) for 15min.
They were then washed, dried and inspected for
precipitates.
Immunoprecipitation and SDS-PAGE analysis of
target components
Immunoprecipitation was performed essentially as
described earlier by Paulie et al. (1984). Briefly,
Nonidet P-40 solubilized extracts of cells labelled
with 1251 by the glucose oxidase/lactoperoxidase
method (Schenkein et al., 1972) were used. Cellular
antigens from total lysates or from ConA-binding
and ConA-passed fractions (Paulie et al., 1983)
were bound to antibodies on a protein-A sepharose
4B matrix (Pharmacia Fine Chemicals, Uppsala,
Sweden) and separated by SDS-PAGE. The gels
were subjected to autoradiography and the mol wts
of precipitated molecules were calculated from their
mobility in relation to standard proteins.
Results
Several fusions with the purpose of producing
hybridomas secreting antibodies specific for
antigens associated with transitional cell carcinoma
of the human urinary bladder (TCC) were
performed. The two immunizing cell lines were (i)
SD, established in our laboratory from a TCC of
grade 3 malignancy (Paulie et al., 1983) and (ii)
TCCSuP, derived from an undifferentiated grade 4
TCC (Nayak et al., 1977). In two fusions of spleen
cells from mice immunized either with TCCSup or
SD, growing hybridomas were selected for antibody
production against the immunizing cell lines. A low
percentage (16 and 20%) of these showed positive
reactions against TCCSup and SD respectively.MOUSE MONOCLONALS TO HUMAN BLADDER CARCINOMA
When tested against cells of non-TCC origin (2T,
LS174T, Ulf and peripheral blood lymphocytes)
two hybridomas (P7A5-4 and SK4H-12) produced
antibodies with little or no activity against these
controls. These were cloned 3 times. As shown by
immunodiffusion against subclass specific rabbit
antisera, antibodies from P7A5-4 were of the IGgl
isotype while SK4H-12 were IgG2a. Crude
supernatants from both hybridomas gave significant
OD values in ELISA up to a dilution of 1:104 and
reaching maximum levels at 1:102 dilution. Re-
activities to components of the serum supplement in
the culture medium were excluded by testing in
ELISA against wells coated with serum proteins as
well as by absorption of the antibodies with serum
proteins coupled to Sepharose. Specificity of the
two antibodies was further assessed against cell
cultures and tissue sections by means of the three
assays: ELISA, IFL and indirect immuno-
peroxidase.
Table I gives the ELISA results obtained with the
two antibodies at a dilution of 1:102. OD values at
405nm over 0.10 were considered as positive. In the
same table an approximation of the staining
intensity as well as the proportion of cells stained in
the IFL test is given. Tissue staining by indirect
immunofluorescence and immunoperoxidase was
adopted in order to determine the antigenic
distribution defined by the two antibodies. Culture
medium and an irrelevant murine monoclonal
antibody (IgGI), specific for human growth
hormone (hGH) but which does not bind to human
cells (results not shown), were used as negative
controls for all tissues. The background level of the
anti-hGH monoclonal did not exceed the culture
medium control in any case.
Monoclonal antibody SK4H-12
Table I shows the reactivity pattern of the SK4H-
12 antibody (mouse immunized with SD). Positive
ELISA reactions were observed with 6 of 7 TCC
cell lines, 4 of which were also tested and found to
be strongly stained in IFL. A strong positive
fluorescence was also obtained with the bladder
carcinoma of squamous cell origin (SCaBER).
SK4H-12 also gave high OD values (405nm) and
an intense staining with the normal urothelial cells.
With the exceptions of the prostate carcinoma line
(HS), which gave a weak reaction in ELISA and
the melanoma line (Ulf) giving a weak staining in
IFL, no reactivity was seen with any of the controls
included in this study. Furthermore, SK4H-12 gave
a homogeneous staining pattern of 7/8 bladder
tumour specimens but so far and as shown in Table
II it did not stain any of the control tissues tested.
One such reaction to a transitional cell carcinoma is
illustrated in Figure 1.
...
Figure 1 Transitional cell carcinoma (fresh frozen)
tested in indirect immunofluorescence with antibody
SK4H-12 (1:10 dilution).
Monoclonal antibody P7A5-4
The antibody P7A5-4 showed positive reactions
with 5 out of 7 TCC cell lines, while little or no
reactivity was observed with the two cells derived
from normal urothelium (Table I). Furthermore,
positive ELISA and/or IFL results were obtained
with the squamous carcinoma line (SCaBER), 2 of 3
colon carcinomas (HT29, HCT8), the 3 melanoma
cell lines (Ulf, Mel-l and CRL-1585), a lung carci-
noma cell line (A427), a prostatic carcinoma (HS)
and lung fibroblasts. No reactivity was observed
with the remaining controls. Results of tissue
staining, summarized in Table II, show that 7 out
of 8 bladder tumours tested were P7A5-4 positive.
The reaction pattern was homogeneous while the
intensity was moderate to strong. Among the
control tissues, weak staining was associated with
prostate epithelium as well as vessel endothelium in
most cases. Furthermore, cryostat sections from
both rat and rabbit organs (bladder, kidney, lung,
liver, spleen, muscle, intestine, heart and stomach)
were not stained by either of the 2 antibodies.
Figure 2 illustrates the staining of a bladder
carcinoma with the P7A5-4 antibody by
immunoperoxidase.
Immunoprecipitation and SDS-PAGE analysis
To determine the cellular target structures for the 2
antibodies, precipitation was performed using NP-
40 extracts of cells surface-labelled with 1251. The
material bound to antibody-ProtA-Sepharose
complexes was analysed on SDS-PAGE followed
by autoradiography. Under reducing conditions,
SK4H-12 precipitated a polypeptide with a mol. wt
of -100Kd present in extracts of SD and T24 cells
(Figure 3). A similar band but at a slightly lower
mol. wt was observed under non-reducing con-
ditions. Moreover, from experiments where the
extracts had been divided into a ConA binding and
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Table I Summary of results obtained with antibodies P7A5-4 and SK4H-12 by cell-ELISA and
IFL
SK4H-12
ELISA IFL
Transitional
cell
carcinoma.
Squamous
carcinoma.
Urothelial
cells.
Colon
carcinoma.
Breast
carcinoma.
Malignant
melanoma.
Osteosarcoma.
Lung
carcinoma.
Prostate
carcinoma.
Lung & Skin
fibroblasts.
Myeloma.
Plasma cell
leukemia.
Blood cells.
Burkitt
lymphoma.
T cell
lymphoma
Erythroleuk.
Histiocytic
lymphoma.
EBV transformed
lymphocytes.
TCCSuPa
SD
EJa
RT4
T24
Hu549
J82
SCaBER
HU-609
HCV-29
HT29
HCT8
LS174T
MCF-7
ULF
MEL-1
CRL-1585
2T
A427
HS
DU145
Fib
F154
SKO
LICR-LON-HMy2
HF-2
+ +
+ +
+
+ +
+ +
+
+ +
+ +(60)
+ +(50)
+++ (90)
+++ (50)
+++ (60)
+++(30)
+++ (90)
P7A5-4
ELISA IFL
+++ +++-(100)
- ++ (50)
++ +++(95)
+
++ +++(90)
++
+++ (60)
+(15)
_ b
_ b
+ b
_ b
_ b
_ b
+(15)
+(20)
+(10)
+(50)
RBC ABO
Sheep/Ox
PBL
Raji
Daudi
Molt4
K562
U937
EBV-lym
ELISA values are given for supernatants diluted 1:100 at OD 405nm and after 60min.
+ ++ =more than 1.0, + + =between 0.5 and 1,0, + =between 0.1 and 0.5, - =less than 0.1.
aPossible sublines of T24 (see text).
bPeroxidase ELISA.
IFL values refer to 1: 10 dilutions. Figures within brackets=percentage oftrained cells. + + + =
strong staining of more than 50% of stained cells, + + =between 20-50% strong staining,
+ =less than 20% strong staining, - =no staining.MOUSE MONOCLONALS TO HUMAN BLADDER CARCINOMA 69
Table II Staining in immunofluorescence and/or immunoperoxidase by
P7A5-4 and SK4H-12 antibodies (1:10 dilutions) of human tissue of
different origin
Monoclonal antibodies
Specimens
Tumour tissue no. SK4H-12 P7A5-4a
Bladder carcinoma 8 +(7)b +(7)b
Breast carcinoma 3 - -
Pancreas carcinoma 1 - -
Lung carcinoma 2 - -
Colonic carcinoma 1
Prostatic carcinoma 1 _ Mc
Malignant melanoma 5
Normal tissue
Bladder 3
Liver 1
Skin 2
Colon 1
Ileum 1 - -
Tonsils 2 - -
Thymus 3 - -
Placenta 2 - -
Lymph node 1 - -
Prostate hyperplasia 3 - +(2)c
+ =positive reactions showing significantly elevated intensity of
staining as compared to background controls. For further details see
text.
Figures within brackets =number of specimens stained.
aEndothelium in most tissues was stained.
bHomogeneous reactivity pattern.
cStaining ofepithelium lining the vesicle ducts.
=no staining.
(a) (b)
Figure 2 Transitional cell carcinoma (fresh frozen) tested by indirect immunoperoxidase. (a) antibody P7A5-4
(1:10 dilution). (b) control staining with culture medium.70 H. BEN-AISSA et al.
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Figure 3 Autoradiograph after SDS-PAGE (6-15%,
reducing conditions) of different '25I-labelled NP40
extracts precipitated with P7A5-4 or SK4H-12
antibodies complexed with protein A-Sepharose 4B.
TCCSuP extract precipitated with P7A5-4 antibodies
(lane A) or with SK4H-12 (lane B). SK4H-12
precipitated extracts of T24 (lane C), SD (lane D),
HT29 (lane E) or LS174T (lane F).
a ConA passed fraction prior to precipitation, the
100Kd component was detected in the ConA
binding fraction of a T24 cell lysate. This molecule
was absent from extracts of TCCSuP, HT29 and
LS174T cells (Figure 3). No precipitates were
detected when the different extracts were incubated
with protein A-Sepharose 4B alone.
In extracts of TCCSuP, P7A5-4 recognized 3
polypeptides (92Kd, 23Kd and 17Kd) (Figure 3), a
pattern that was consistent irrespective of whether
the gels were run under reduced or non-reduced
conditions. The two low molecular components
(23 Kd and 17Kd) were found to reside in the
ConA passed fraction, while the 92Kd was a ConA
binding glycoprotein (data not shown). None of the
3 components was precipitated with lysates of SD
or LS174T cells which were negative in ELISA or
with HT29 which was positive.
Discussion
The aim of this study was to raise antibodies
specific for urinary bladder carcinoma and to
elucidate whether these could define new structures
of potential value for diagnosis and therapy. The
immunizing schedule adopted was chosen to allow
antigens of poor immunogenicity or low cellular
expression to give rise to an immune response. For
screening of hybridoma supernatants, we used IFL
and a cell-ELISA similar to that described by Suter
et al. (1980). A detailed description of the cell-
ELISA developed in our laboratory has been given
elsewhere (Koho et al., 1984). Due to endogenous
alkaline phosphatase activity or other reasons, some
cell lines were tested in a peroxidase ELISA or only
by IFL. Cryostat sections from frozen tissues were
tested by IFL and an indirect immunoperoxidase
staining method.
The occurrence of cross-contamination between
urothelial cell lines has been discussed recently by
O'Toole et al. (1983). To establish the identity of
the urothelial cell lines on our target cell panel,
tests for HLAA,B specificity in ADCC (O'Toole et
al., 1982) and HLADR/DC specificity by DNA
blotting and hybridization with cDNA probes
(Andersson et al., 1984), were performed (B.
Karlsson et al., in preparation). On the basis of
these tests, 5 TCC cell lines, (T24, J82, SD, RT4,
HU549) and 2 cell lines derived from normal
urothelium (HU609 and HCV29) were clearly
distinct from each other. When compared to T24,
the 2 cell lines TCCSuP and EJ appeared to be
identical in HLAA,B expression and homologous
in the DR/DC loci. However, as they differed in
growth pattern as well as morphology and
displayed differences in antigen expression, they
were included on our cell panel. The possibility that
these 2 lines constitute sublines of T24 is not
excluded.
When examining the antibody secreted by
hybridoma SK4H-12 against a panel of cultured
target cells, positive reactions were seen with 9/10
urothelium derived cells, including those of normal
origin. From 25 non-urothelial cell types only 2
(HS and ULF) showed reactivity. The. significance
of these reactions is, however, doubtful since
reactivity in both cases was only observed with one
of the two assays and gave values only slightly over
background. Immunohistochemical staining of
tissue sections with SK4H-12 showed a similar
selective pattern of reactivity. While staining the
majority of TCC specimens (7/8), no reaction has
so far been detected with any of the non-TCC adult
tissues included in this study. Interestingly and in
contrast to what was seen for cultured cells, SK4H-
12 gave no visible staining of normal urothelium.
Although this has to be confirmed by testing
further material from normal bladder, it suggests
that the cells in culture may have acquired some
phenotypic characters of malignant cells. A
premalignant phenotype of these cells is also
supported by an apparently indefinite lifespan.
However, they lack the ability to grow in nude mice
and show a diploid karyotype (Vilien et al., 1983).
Results of the antigen studies presented herein
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glycoprotein of mol. wt 100Kd, present in lysates
of both SD and T24 cells but absent from extracts
of SK4H-12 negative cell lines (TCCSuP, HT29 and
LS174-T).
The other antibody, P7A5-4, displayed a specificity
pattern similar to that of three other TCC-related
antibodies previously found in our laboratory
(Koho et al., 1984). As these also precipitated
polypeptides of the same molecular size, they are
likely to be directed against the same target antigen.
Differences in reactivity with individual cell lines
suggest, however, that they recognize separate
epitopes. The P7A5-4 antibody could clearly
discriminate between malignant and normal cells
from the bladder, both when tested with cultured
cells and fresh tissue. On cell lines the antibody also
showed a positive reactivity with some non-TCC
and melanoma cells. However, for most of these
cells the detected reactions were significantly lower
indicating a quantitative difference in antigen
expression by TCC and other cells. This difference
in the level of expression was even more
pronounced when tested with fresh tumours. A
moderate to strong homogeneous staining was seen
with 7 out of 8 TCC specimens while 8 non-related
carcinomas as well as 5 melanomas failed to given
any visible reaction. The P7A5-4 antigen was,
however, not entirely restricted to TCC cells since a
weak staining was also observed in association with
the epithelium lining some of the vesicle ducts
within the prostate as well as the vessel
endothelium of some tissues. These reactivities
have to be further elucidated, especially since the
endothelium represented an area frequently seen to
give elevated background staining. For this purpose
we are presently setting up in vitro cultures of
endothelial cells derived from the umbilical cord.
The major components precipitated with both of
these antibodies, 100Kd for SK4H-12 and 92Kd
for P7A5-4, are found in a molecular size range
where TAAs of other tumours have previously been
identified with mouse monoclonals. These include
the 94Kd polypeptide described by Imai et al.
(1982) to be associated with melanomas and
carcinomas and the p97 reported by two groups
(Woodburry et al., 1980; Dippold et al., 1980) to be
preferentially expressed on melanomas and some
carcinomas. However, judging from the cellular
distribution of these antigens as well as the lack of
coprecipitated low molecular polypeptides, the
92Kd as well as the 100Kd appear to represent
distinct antigens.
A difference in cellular restriction was also
established for one of these melanoma-associated
antigens, p97, when antibodies to this molecule (a
gift from Dr K.E. Hellstrom) were tested in ELISA
against the same cell panel. The two polypeptides
appear also to be separate from the transferrin
receptor, as antibodies to this molecule (OKT9,
Sutherland et al., 1981) detect a polypeptide of
-180Kd when run on SDS-PAGE under non-
reducing conditions and a band of slightly higher
mol. wt (95Kd) than the 92Kd under reducing
conditions (results not shown). Furthermore,
similarity in molecular size between the major low
mol. wt component (23Kd) and the ras gene
product p21 (Chang et al., 1982) known to be well
expressed in some TCC cells, raised the question
whether the two molecules might be identical.
However, radiolabelled TCC cell extracts
precipitated by antibodies to either the p21 or the
23Kd molecules showed distinct migration profiles
(G.M. Cooper, personal communications), thus
suggesting a non-identity of these molecules.
Monoclonal antibodies reactive with TCC
associated antigens have recently been reported by
other groups (Fradet et al., 1984; Mazuko et al.,
1984; Messing et al., 1984; Grossman, 1983).
However, comparison of these findings with our
own data suggests that none of these antibodies is
likely to be identical to the ones described herein.
Within the limits and sensitivity of the tests
performed in this study, the antigenic targets for
the SK4H-12 and P7A5-4 antibodies were shown to
be expressed in a highly selective manner. Both
were found on a majority of TCC cells but were
absent from normal urothelial tissue. Although the
distributional pattern of the antigens makes them
potentially useful as markers for bladder
carcinoma, conclusions regarding specifity have to
await further tests on various tissues of malignant,
normal and foetal origin.
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